|
|
Volumn 2, Issue 5, 2001, Pages 421-429
|
|
Advanced testis cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TUMOR MARKER;
ALGORITHM;
BLOOD;
CANCER STAGING;
EPIDEMIOLOGY;
HUMAN;
IMPOTENCE;
LYMPH NODE METASTASIS;
LYMPHADENECTOMY;
MALE;
METASTASIS;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
ORCHIECTOMY;
PATHOLOGY;
POSTOPERATIVE COMPLICATION;
PROGNOSIS;
RADIATION DOSE;
RETROPERITONEAL TUMOR;
REVIEW;
RISK FACTOR;
SALVAGE THERAPY;
SEMINOMA;
SURVIVAL RATE;
TESTIS TUMOR;
TREATMENT OUTCOME;
ALGORITHMS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COMBINED MODALITY THERAPY;
EPIDEMIOLOGIC METHODS;
HUMANS;
IMPOTENCE;
LYMPH NODE EXCISION;
LYMPHATIC METASTASIS;
MALE;
NEOPLASM METASTASIS;
NEOPLASM STAGING;
ORCHIECTOMY;
POSTOPERATIVE COMPLICATIONS;
PROGNOSIS;
RADIATION TOLERANCE;
RETROPERITONEAL NEOPLASMS;
RISK FACTORS;
SALVAGE THERAPY;
SEMINOMA;
SURVIVAL RATE;
TESTICULAR NEOPLASMS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0035495953
PISSN: 15272729
EISSN: None
Source Type: Journal
DOI: 10.1007/s11864-001-0047-z Document Type: Review |
|
Times cited : (6)
|
|
References (32)
|
